New TB cocktail drug holds great promise

Drug Discovery |  Analysis | By BioSpectrum Bureau  | 0 Comment | 27 Jul, 2012

Singapore: A novel anti-TB drug has generated encouraging results in a recent Phase II trial funded by the non-profit TB...Read more

Singapore univ prepares for trial of glaucoma drug

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 12 Feb, 2013

Singapore: For glaucoma patients, taking daily medication will soon become a thing of the past. With Nanyang Technologic...Read more

BioDuro opens discovery lab in Shanghai

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 16 May, 2013

Singapore: BioDuro, a PPD Company, has opened a new state-of-the-art laboratory in Shanghai, China, strengthening its ab...Read more

FDA approves ZALTRAP for colorectal cancer

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 1 Comment | 06 Aug, 2012

Singapore: Sanofi and Regeneron Pharmaceuticals have received US Food and Drug Administration (FDA) approval for ZALTRAP...Read more

Report on strategies to manage patent protection loss

Drug Discovery |  Analysis | By BioSpectrum Bureau  | 1 Comment | 06 Jul, 2012

Singapore: Exclusivity is everything in the pharmaceutical brand business. Without it, power over pricing disappears and...Read more

Eisai cancer drug gets orphan drug designation from Japan

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 27 Aug, 2012

Singapore: Eisai has received orphan drug designation from Japan's Ministry of Labour, Health and Welfare for its multi...Read more

QRx Pharma gets FDA inputs on Moxduo

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 09 Oct, 2013

Singapore: Australia-based QRxPharma is proceeding with US FDA to discuss the company's Moxduo new drug application (NDA...Read more

Daiichi Sankyo enrolls patients for edoxaban trial

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 30 Oct, 2012

Singapore: Japan-headquartered Daiichi Sankyo has completed patient enrollment in the global Hokusai-VTE phase III study...Read more

Daiichi, Amplimmune join hands for protein R&D

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jan, 2013

Singapore: Daiichi Sankyo and Amplimmune have entered into a strategic collaboration to develop a new therapeutic prote...Read more

Sankyo halts phase III trial of cancer drug

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 04 Oct, 2012

Singapore: The independent Data Monitoring Committee (DMC) of the phase III MARQUEE (Met inhibitor ARQ 197 plus Erlotin...Read more

Women are on greater risk for Alzheimer's disease: Report

Drug Discovery |  Analysis | By BioSpectrum Bureau  | 1 Comment | 17 Apr, 2014

Singapore: Carrying a copy of a gene variant called ApoE4 confers a substantially greater risk for Alzheimer's disease o...Read more

Boehringer Ingelheim´s Volasertib gets orphan drug designation in EU, US

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 1 Comment | 17 Apr, 2014

Singapore: US Food and Drug Administration (FDA) and the European Commission have granted orphan drug designation to Boe...Read more

Money churning drugs of 2014: Report

Drug Discovery |  Analysis | By BioSpectrum Bureau  | 0 Comment | 17 Apr, 2014

Singapore: Gilead's drug Sovaldi for hepatitis C virus, GlaxoSmithKline/Theravance's Anoro Ellipta for Chronic Obstructi...Read more

Johnson & Johnson acquires Aragon Pharma

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 21 Aug, 2013

Singapore: Johnson & Johnson has acquired Aragon Pharmaceuticals, a privately-held pharmaceutical discovery and deve...Read more

Chinese medicine improves spinal injury in rats

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 21 Aug, 2013

Singapore: A new study published in Restorative Neurology and Neuroscience demonstrates that Chinese herbal medicine Ji-...Read more

Eisai, UCL form neuro R&D alliance

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 14 Dec, 2012

Singapore: University College London (UCL) and Japanese pharmaceutical company Eisai, have entered into a new agreement ...Read more

Novartis has a substantial drug pipeline for all diseases

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 09 Nov, 2012

Singapore: Novartis planning to leverage on its R&D pipeline to taste commercial success through 2017. Continuing R&...Read more

Taiwan research centre to develop dengue vaccine with Janssen

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jun, 2015

Singapore: BRIM Biotechnology has collaborated with Janssen Pharmaceutica to pursue research, development and commercial...Read more